Xylem (XYL)
(Delayed Data from NYSE)
$134.51 USD
-0.30 (-0.22%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $134.57 +0.06 (0.04%) 4:40 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Balance Sheet
Fiscal Year End for Xylem Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,019 | 944 | 1,349 | 1,875 | 724 |
Receivables | 1,617 | 1,096 | 953 | 923 | 1,036 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,018 | 799 | 700 | 558 | 539 |
Other Current Assets | 230 | 173 | 158 | 167 | 151 |
Total Current Assets | 3,884 | 3,012 | 3,160 | 3,523 | 2,450 |
Net Property & Equipment | 1,169 | 630 | 644 | 657 | 658 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 10,116 | 3,649 | 3,808 | 3,947 | 4,013 |
Deposits & Other Assets | 943 | 661 | 664 | 623 | 589 |
Total Assets | 16,112 | 7,952 | 8,276 | 8,750 | 7,710 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 968 | 723 | 639 | 569 | 597 |
Current Portion Long-Term Debt | 16 | 0 | 0 | 600 | 276 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,221 | 867 | 752 | 787 | 628 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2,205 | 1,590 | 1,391 | 1,956 | 1,501 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 557 | 222 | 287 | 242 | 310 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,268 | 1,880 | 2,440 | 2,484 | 2,040 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 906 | 757 | 932 | 1,092 | 892 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5,936 | 4,449 | 5,050 | 5,774 | 4,743 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 2 | 2 | 2 | 2 |
Capital Surplus | 8,564 | 2,134 | 2,089 | 2,037 | 1,991 |
Retained Earnings | 2,601 | 2,292 | 2,154 | 1,930 | 1,866 |
Other Equity | -259 | -217 | -363 | -405 | -365 |
Treasury Stock | 733 | 708 | 656 | 588 | 527 |
Total Shareholder's Equity | 10,176 | 3,503 | 3,226 | 2,976 | 2,967 |
Total Liabilities & Shareholder's Equity | 16,112 | 7,952 | 8,276 | 8,750 | 7,710 |
Total Common Equity | 10,176 | 3,503 | 3,226 | 2,976 | 2,967 |
Shares Outstanding | 241.00 | 180.20 | 180.30 | 180.20 | 180.00 |
Book Value Per Share | 42.22 | 19.44 | 17.89 | 16.51 | 16.48 |
Fiscal Year End for Xylem Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 815 | 947 | 1,019 | 705 | 708 |
Receivables | 1,675 | 1,641 | 1,617 | 1,653 | 1,659 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,057 | 1,039 | 1,018 | 1,080 | 1,143 |
Other Current Assets | 234 | 266 | 230 | 213 | 225 |
Total Current Assets | 3,781 | 3,893 | 3,884 | 3,651 | 3,735 |
Net Property & Equipment | 1,144 | 1,141 | 1,169 | 1,132 | 1,144 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 9,883 | 9,963 | 10,116 | 10,188 | 10,296 |
Deposits & Other Assets | 957 | 927 | 943 | 934 | 922 |
Total Assets | 15,765 | 15,924 | 16,112 | 15,905 | 16,097 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 940 | 948 | 968 | 943 | 968 |
Current Portion Long-Term Debt | 17 | 285 | 16 | 17 | 240 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,085 | 1,098 | 1,221 | 1,160 | 1,074 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2,042 | 2,331 | 2,205 | 2,120 | 2,282 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 552 | 558 | 557 | 724 | 738 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,981 | 1,985 | 2,268 | 2,253 | 2,267 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 842 | 906 | 867 | 900 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5,417 | 5,721 | 5,936 | 5,964 | 6,187 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 8,660 | 8,618 | 8,564 | 8,529 | 8,495 |
Retained Earnings | 2,774 | 2,667 | 2,601 | 2,416 | 2,344 |
Other Equity | -338 | -337 | -259 | -289 | -215 |
Treasury Stock | 751 | 748 | 733 | 718 | 717 |
Total Shareholder's Equity | 10,348 | 10,203 | 10,176 | 9,941 | 9,910 |
Total Liabilities & Shareholder's Equity | 15,765 | 15,924 | 16,112 | 15,905 | 16,097 |
Total Common Equity | 10,348 | 10,203 | 10,176 | 9,941 | 9,910 |
Shares Outstanding | 242.80 | 242.40 | 241.00 | 241.00 | 240.80 |
Book Value Per Share | 42.62 | 42.09 | 42.22 | 41.25 | 41.15 |